Panacea Biotec

Rediff.com » News » Panacea Biotec

News for Panacea Biotec

News
Business

First-ever phase-3 trial for dengue vaccine begins in India

The Indian Council of Medical Research (ICMR) and Panacea Biotec have initiated the first-ever phase three clinical trial for developing a dengue vaccine in India, the Union Health Ministry said on......

Sputnik V production begins in India; 100mn jabs to be manufactured per year

Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund (RDIF) has begun the production of 'Sputnik V' COVID-19 vaccine in......

India's First Dengue Vaccine Likely To Be Ready By 2026

Dengue has become a major public health concern in India with 289,235 cases reported last year. This year there were 19,447 cases of dengue which resulted in 19 deaths till April 2024. Kindly......

Govt officers living in ivory towers, not alive to Covid situation: HC

COVID-19 has not spared even a single family and still central government's officers are living in "ivory towers" oblivious of ground realities, observed the Delhi high court which on Tuesday was......

Charge officers sitting over vaccine production with manslaughter: HC

Officers sitting over untapped potential to make COVID-19 vaccines need to be charged with 'manslaughter' as it is leading to so many deaths, the Delhi high court said on Wednesday, observing that......

Five Indians among 40 influential pharma faces

London-based SPG Media, publishers of the annual World Pharmaceutical Frontiers survey, has included five Indians among the top 40 influential people in the global pharmaceutical industry in 2008.......

Panacea gets WHO accreditation for Hep-B vaccine

Panacea Biotec Ltdsaid on Wednesday it has received pre-qualification accreditation from the World Health Organisationfor the supply of recombinant Hepatitis B vaccine to UN agencies.Hepatitis B......

WHO refuses vaccine approval

The World Health Organization has not approved any new vaccine from India this year as the Indian regulatory system, which gives manufacturing licences for domestic vaccines, has failed to meet its......

India's biotech export touches $1.2 billion

India's export revenue from biotechnology grew by 47 percent to reach 1.2 billion dollars in the financial year ended March 2007, a survey said.According to a survey conducted by the Association on......

Panacea eyes Latin America

Panacea Biotec is planning to launch its organ transplantation drugs to Latin American and South East Asian markets. The company is also looking for enlarging the scope of organ transplantation......

Panacea Biotec

News for Panacea Biotec

First-ever phase-3 trial for dengue vaccine begins in India

Sputnik V production begins in India; 100mn jabs to be manufactured per year

India's First Dengue Vaccine Likely To Be Ready By 2026

Govt officers living in ivory towers, not alive to Covid situation: HC

Charge officers sitting over vaccine production with manslaughter: HC

Five Indians among 40 influential pharma faces

Panacea gets WHO accreditation for Hep-B vaccine

WHO refuses vaccine approval

India's biotech export touches $1.2 billion

Panacea eyes Latin America

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS